Fremanezumab bulk supplier for pharma manufacturers

Fremanezumab 225 mg / 1.5 mL Suppliers & Bulk Manufacturers

Available Forms: Prefilled syringe

Available Strengths: 225 mg / 1.5 mL

Reference Brands: Ajovy (USA/EU)

Category: Neurology

Fremanezumab is a monoclonal antibody that targets the CGRP receptor, a protein involved in the transmission of pain and the development of migraines. By inhibiting this receptor, fremanezumab helps to prevent the onset of migraine attacks. It is administered via subcutaneous injection, with dosing options tailored to patient needs and preferences.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Fremanezumab — third party manufacturing & bulk supply

Fremanezumab 225 mg / 1.5 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Fremanezumab is supplied as Prefilled syringe — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Fremanezumab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Fremanezumab →

Back to Listing

Frequently Asked Questions

Fremanezumab is listed as Prefilled syringe in 225 mg / 1.5 mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Fremanezumab is referenced against Ajovy (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.